(Q42602624)

3 November 2017

Strain-dependent recovery of open-field behavior and striatal dopamine deficiency in the mouse MPTP model of Parkinson's disease (English)

1 reference

3 November 2017

0 references

1 reference

Schwarting RK

1

1 reference

3 November 2017

Sedelis M

2

1 reference

3 November 2017

Hofele K

3

1 reference

3 November 2017

Auburger GW

4

1 reference

3 November 2017

Huston JP

5

1 reference

3 November 2017

1 September 1999

1 reference

3 November 2017

Neurotoxicity Research

1 reference

3 November 2017

1

1 reference

3 November 2017

1

1 reference

3 November 2017

41-56

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03033338

3 November 2017

0 references

cites work

The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments

1 reference

12 December 2020

Intranigral grafts of fetal ventral mesencephalic tissue in adult 6-hydroxydopamine-lesioned rats can induce behavioral recovery.

1 reference

12 December 2020

MPTP-induced hypoactivity in mice: reversal by L-dopa.

1 reference

12 December 2020

The effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal and limbic catecholamine neurones in white and black mice. Antagonism by monoamine oxidase inhibitors.

1 reference

12 December 2020

GM1 gangliosides alter acute MPTP-induced behavioral and neurochemical toxicity in mice

1 reference

12 December 2020

Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice.

1 reference

12 December 2020

The acute effect on levels of catecholamines and metabolites in brain, of a single dose of MPTP in 8 strains of mice

1 reference

12 December 2020

The involvement of nucleus accumbens dopamine in appetitive and aversive motivation.

1 reference

12 December 2020

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level.

1 reference

12 December 2020

Behavioral and biochemical changes following acute administration of MPTP and MPP+

1 reference

12 December 2020

Longitudinal behavioral and 6-[18F]fluoro-L-DOPA-PET assessment in MPTP-hemiparkinsonian monkeys

1 reference

12 December 2020

Neurochemical evaluation of the striatum in symptomatic and recovered MPTP-treated cats

1 reference

12 December 2020

Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae

1 reference

12 December 2020

MPTP produces differential oxidative stress and antioxidative responses in the nigrostriatal and mesolimbic dopaminergic pathways.

1 reference

12 December 2020

1 reference

12 December 2020

Early behavioral changes after nigro-striatal system damage can serve as predictors of striatal dopamine depletion

1 reference

12 December 2020

Destruction of norepinephrine terminals in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice reduces locomotor activity induced by L-dopa

1 reference

12 December 2020

The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse

1 reference

12 December 2020

The overall rod performance test in the MPTP-treated-mouse model of Parkinsonism.

1 reference

12 December 2020

Symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates: biochemical changes in striatal regions

1 reference

12 December 2020

Acute stress or neuroleptics elicit sensorimotor deficits in MPTP-treated mice

1 reference

12 December 2020

Neurotoxicity of MPTP and uptake of MPPT into dopamine and norepinephrine neurons in mice

1 reference

12 December 2020

Dopamine receptors and sensorimotor behavior in MPTP-treated mice.

1 reference

12 December 2020

Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL/6 mice: a model for Parkinson's disease.

1 reference

12 December 2020

The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice.

1 reference

12 December 2020

HemiParkinson analogue rats display active support in good limbs versus passive support in bad limbs on a skilled reaching task of variable height

1 reference

12 December 2020

The mesolimbic dopaminergic pathway is more resistant than the nigrostriatal dopaminergic pathway to MPTP and MPP+ toxicity: role of BDNF gene expression.

1 reference

12 December 2020

Low dopamine transporter mRNA levels in midbrain regions containing calbindin.

1 reference

12 December 2020

Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man.

1 reference

12 December 2020

Mechanisms of MPTP toxicity.

1 reference

12 December 2020

Compensations after lesions of central dopaminergic neurons: some clinical and basic implications

1 reference

12 December 2020

MPTP-induced behavioural and biochemical deficits: a parametric analysis

1 reference

12 December 2020

Histochemical, biochemical and behavioural consequences of MPTP treatment in C-57 black mice

1 reference

12 December 2020

Effects of MPTP on locomotor activity in mice

1 reference

12 December 2020

Short-term effects of ether, equithesin and droperidol/fentanyl on catecholamine and indolamine metabolism in the brain of the rat.

1 reference

12 December 2020

Dissociation of serotoninergic and dopaminergic components in acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice

1 reference

12 December 2020

Behavioral indices of moderate nigro-striatal 6-hydroxydopamine lesion: a preclinical Parkinson's model.

1 reference

12 December 2020

Behavioral asymmetries and recovery in rats with different degrees of unilateral striatal dopamine depletion

1 reference

12 December 2020

Behavioral and biochemical effects of nicotine in an MPTP-induced mouse model of Parkinson's disease.

1 reference

12 December 2020

The neurotoxin MPTP increases calbindin-D28k levels in mouse midbrain dopaminergic neurons.

1 reference

12 December 2020

Manganese superoxide dismutase overexpression attenuates MPTP toxicity.

1 reference

12 December 2020

Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the substantia nigra and the locus coeruleus in BALB/c mice

1 reference

12 December 2020

Morphological, neurochemical, and behavioral characterizations associated with the combined treatment of diethyldithiocarbamate and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice

1 reference

12 December 2020

Studies on the effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in C57BL/6 mice. Comparison with three other strains of mice

1 reference

12 December 2020

Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 5,7-dihydroxytryptamine on the locomotor activity and striatal amines in C57BL/6 mice.

1 reference

12 December 2020

Regional differences in striatal dopamine uptake and release associated with recovery from MPTP-induced parkinsonism: an in vivo electrochemical study.

1 reference

12 December 2020

A simple quantitative bradykinesia test in MPTP-treated mice.

1 reference

12 December 2020

Motor function in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse

1 reference

12 December 2020

Differential behavioural effects after subtotal depletions of dopamine or noradrenaline in the ventral striatum.

1 reference

12 December 2020

Differences in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57/bl and CD-1 mice.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03033338

1 reference

3 November 2017

1 reference